Terms: = Leukemia AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Diagnosis
17 results:
1. Fluorescence biosensing of the leukemia gene by combining Target-Programmed controllable signal inspiring engineering.
Li H; Pu J; Wang S; Yu R
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121579. PubMed ID: 35803107
[TBL] [Abstract] [Full Text] [Related]
2. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
[TBL] [Abstract] [Full Text] [Related]
3. Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia.
Wang R; Cong Y; Li C; Zhang C; Lin H
Medicine (Baltimore); 2019 Apr; 98(15):e15222. PubMed ID: 30985724
[TBL] [Abstract] [Full Text] [Related]
4. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
Chow YP; Alias H; Jamal R
BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
[TBL] [Abstract] [Full Text] [Related]
5. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India.
Mhatre S; Madkaikar M; Desai M; Ghosh K
Blood Cells Mol Dis; 2015 Mar; 54(3):250-7. PubMed ID: 25577959
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
[TBL] [Abstract] [Full Text] [Related]
7. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
Cota C; Vale E; Viana I; Requena L; Ferrara G; Anemona L; Metze D; Fink-Puches R; Wiesner T; Cerroni L
Am J Surg Pathol; 2010 Jan; 34(1):75-87. PubMed ID: 19956058
[TBL] [Abstract] [Full Text] [Related]
8. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
[TBL] [Abstract] [Full Text] [Related]
9. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
[TBL] [Abstract] [Full Text] [Related]
10. Interphase fluorescence in situ hybridization assay for the detection of rearrangements of the EVI-1 locus in chromosome band 3q26 in myeloid malignancies.
Wieser R; Schreiner U; Rieder H; Pirc-Danoewinata H; Grüner H; Loncarevic IF; Fonatsch C
Haematologica; 2003 Jan; 88(1):25-30. PubMed ID: 12551823
[TBL] [Abstract] [Full Text] [Related]
11. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract] [Full Text] [Related]
12. Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia.
Rowe D; Breese GJ; Lennard A; Bown N
Genes Chromosomes Cancer; 2002 May; 34(1):126-8. PubMed ID: 11921290
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms.
Palumbo C; van Roozendaal K; Gillis AJ; van Gurp RH; de Munnik H; Oosterhuis JW; van Zoelen EJ; Looijenga LH
J Pathol; 2002 Apr; 196(4):467-77. PubMed ID: 11920744
[TBL] [Abstract] [Full Text] [Related]
14. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
[TBL] [Abstract] [Full Text] [Related]
15. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19).
Raimondi SC; Behm FG; Roberson PK; Williams DL; Pui CH; Crist WM; Look AT; Rivera GK
J Clin Oncol; 1990 Aug; 8(8):1380-8. PubMed ID: 2380759
[TBL] [Abstract] [Full Text] [Related]
16. Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal alpha 1-4Gal beta 1-4Glc beta-O and Gal alpha 1-4Gal beta 1-4GlcNAc beta-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies.
Brodin NT; Dahmén J; Nilsson B; Messeter L; Mårtensson S; Heldrup J; Sjögren HO; Lundblad A
Int J Cancer; 1988 Aug; 42(2):185-94. PubMed ID: 2456994
[TBL] [Abstract] [Full Text] [Related]
17. [Significance of PAS-positive myeloblastic leukemia].
Abbrederis K; Schmalzl F; Braunsteiner H
Blut; 1976 Aug; 33(2):103-8. PubMed ID: 61050
[TBL] [Abstract] [Full Text] [Related]
